DnB Asset Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.42M | Buy |
39,746
+661
| +2% | +$58K | 0.01% | 546 |
|
|
2026
Q1 | $3.53M | Buy |
39,085
+1,758
| +5% | +$161K | 0.01% | 510 |
|
|
2025
Q4 | $3.36M | Hold |
37,327
| – | – | 0.01% | 524 |
|
|
2025
Q3 | $3.68M | Buy |
37,327
+1,894
| +5% | +$188K | 0.01% | 495 |
|
|
2025
Q2 | $3.23M | Sell |
35,433
-794
| -2% | -$76.8K | 0.01% | 478 |
|
|
2025
Q1 | $4.1M | Sell |
36,227
-770
| -2% | -$82.4K | 0.02% | 418 |
|
|
2024
Q4 | $3.91M | Buy |
36,997
+957
| +3% | +$103K | 0.02% | 435 |
|
|
2024
Q3 | $3.89M | Buy |
36,040
+585
| +2% | +$63.8K | 0.02% | 429 |
|
|
2024
Q2 | $3.85M | Buy |
35,455
+2,597
| +8% | +$306K | 0.02% | 396 |
|
|
2024
Q1 | $4.34M | Buy |
32,858
+1,256
| +4% | +$157K | 0.02% | 377 |
|
|
2023
Q4 | $3.85M | Buy |
31,602
+966
| +3% | +$108K | 0.02% | 416 |
|
|
2023
Q3 | $3.44M | Sell |
30,636
-3,283
| -10% | -$417K | 0.02% | 432 |
|
|
2023
Q2 | $4.94M | Sell |
33,919
-29,078
| -46% | -$3.95M | 0.03% | 358 |
|
|
2023
Q1 | $8.14M | Sell |
62,997
-161
| -0.3% | -$20.2K | 0.05% | 262 |
|
|
2022
Q4 | $8.05M | Buy |
63,158
+1,625
| +3% | +$189K | 0.06% | 260 |
|
|
2022
Q3 | $6.43M | Sell |
61,533
-1,217
| -2% | -$134K | 0.05% | 286 |
|
|
2022
Q2 | $6.59M | Sell |
62,750
-1,140
| -2% | -$135K | 0.05% | 290 |
|
|
2022
Q1 | $8.17M | Buy |
63,890
+33,976
| +114% | +$4.1M | 0.05% | 284 |
|
|
2021
Q4 | $3.69M | Buy |
29,914
+3,223
| +12% | +$422K | 0.02% | 438 |
|
|
2021
Q3 | $3.79M | Buy |
26,691
+1,121
| +4% | +$165K | 0.02% | 402 |
|
|
2021
Q2 | $3.99M | Sell |
25,570
-5,859
| -19% | -$949K | 0.03% | 414 |
|
|
2021
Q1 | $4.88M | Buy |
31,429
+4,531
| +17% | +$702K | 0.04% | 324 |
|
|
2020
Q4 | $4.02M | Buy |
26,898
+3,305
| +14% | +$467K | 0.04% | 313 |
|
|
2020
Q3 | $3.12M | Buy |
23,593
+2,104
| +10% | +$275K | 0.03% | 307 |
|
|
2020
Q2 | $2.49M | Buy |
21,489
+1,192
| +6% | +$137K | 0.03% | 341 |
|
|
2020
Q1 | $1.99M | Sell |
20,297
-3,743
| -16% | -$491K | 0.03% | 339 |
|
|
2019
Q4 | $3.49M | Buy |
24,040
+1,171
| +5% | +$162K | 0.03% | 314 |
|
|
2019
Q3 | $3.05M | Buy |
22,869
+516
| +2% | +$66.7K | 0.03% | 339 |
|
|
2019
Q2 | $2.56M | Sell |
22,353
-2,087
| -9% | -$244K | 0.03% | 363 |
|
|
2019
Q1 | $3.03M | Sell |
24,440
-2,098
| -8% | -$238K | 0.03% | 312 |
|
|
2018
Q4 | $2.67M | Sell |
26,538
-951
| -3% | -$107K | 0.03% | 309 |
|
|
2018
Q3 | $3.51M | Buy |
27,489
+1,937
| +8% | +$230K | 0.04% | 290 |
|
|
2018
Q2 | $2.76M | Buy |
25,552
+1,030
| +4% | +$112K | 0.03% | 322 |
|
|
2018
Q1 | $2.6M | Buy |
24,522
+2,266
| +10% | +$263K | 0.03% | 323 |
|
|
2017
Q4 | $2.61M | Hold |
22,256
| – | – | 0.03% | 316 |
|
|
2017
Q3 | $2.53M | Hold |
22,256
| – | – | 0.03% | 296 |
|
|
2017
Q2 | $2.77M | Sell |
22,256
-618
| -3% | -$73.3K | 0.04% | 275 |
|
|
2017
Q1 | $2.71M | Buy |
22,874
+3,193
| +16% | +$362K | 0.04% | 278 |
|
|
2016
Q4 | $1.97M | Buy |
19,681
+2,060
| +12% | +$221K | 0.04% | 285 |
|
|
2016
Q3 | $2.22M | Buy |
17,621
+1,339
| +8% | +$165K | 0.04% | 253 |
|
|
2016
Q2 | $1.9M | Sell |
16,282
-45,938
| -74% | -$5.2M | 0.04% | 272 |
|
|
2016
Q1 | $6.44M | Buy |
62,220
+51,912
| +504% | +$5.02M | 0.13% | 129 |
|
|
2015
Q4 | $1.03M | Sell |
10,308
-618
| -6% | -$60.5K | 0.02% | 312 |
|
|
2015
Q3 | $996K | Buy |
+10,926
| New | +$1.1M | 0.02% | 309 |
|
|
2015
Q1 | – | Sell |
-12,332
| Closed | -$1.36M | – | 483 |
|
|
2014
Q4 | $1.36M | Sell |
12,332
-12,772
| -51% | -$1.35M | 0.03% | 300 |
|
|
2014
Q3 | $2.45M | Sell |
25,104
-424,327
| -94% | -$41.7M | 0.05% | 194 |
|
|
2014
Q2 | $45.3M | Buy |
+449,431
| New | +$43.9M | 0.96% | 32 |
|
|
2013
Q4 | $43.2M | Sell |
477,430
-680
| -0.1% | -$58.8K | 1.01% | 31 |
|
|
2013
Q3 | $38.1M | Sell |
478,110
-207,877
| -30% | -$16.4M | 1.04% | 36 |
|
|
2013
Q2 | $49.9M | Buy |
+685,987
| New | +$51.3M | 1.48% | 18 |
|
Other funds holding ZBH
EIC
DnB Asset Management's ZBH Position: Q2 2026 in Review
DnB Asset Management increased its Zimmer Biomet (ZBH) stake by 1.7% in Q2 2026, buying an estimated $58K and bringing the position to 39,746 shares worth $3.42M. The position accounts for 0.01% of the portfolio, ranked #546.
DnB Asset Management first reported a position in ZBH in Q2 2013 and has held it in 50 quarters since. The position peaked at $49.9M in Q2 2013. 645 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.
- DnB Asset Management held 39,746 shares of Zimmer Biomet worth $3.42M as of Q2 2026.
- DnB Asset Management bought 661 Zimmer Biomet shares in Q2 2026, an estimated $58K.
- Zimmer Biomet made up 0.01% of DnB Asset Management's portfolio in Q2 2026, its #546 holding.
- DnB Asset Management first reported a position in Zimmer Biomet in Q2 2013 and has held it in 50 quarters since.
- DnB Asset Management's Zimmer Biomet position peaked at $49.9M in Q2 2013.
- 645 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.
Based on DnB Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.